Wordt geladen...
Personalising medicine in inflammatory bowel disease—current and future perspectives
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe and extensive disease, leading to significant morbidity including delayed growth and nutritional impairment. The classical approach to management has centred on differentiation into Crohn’s disease (CD) or ulc...
Bewaard in:
| Gepubliceerd in: | Transl Pediatr |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382508/ https://ncbi.nlm.nih.gov/pubmed/30881899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp.2018.12.03 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|